PATENT CLAIM ANALYSIS

Application Number: 16129944
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "255050"]

Abstract:
Provided herein are 3-phenyl-7-hydroxy-isocoumarin compounds which are MIF inhibitors; compositions comprising said inhibitors and methods for treating or preventing diseases associated with MIF.

Claim (Index 55):
The method of treating cancer as claimed in  claim 52 , wherein the cancer is selected from the group consisting of: lung cancer, ovarian cancer, breast cancer, hepatocellular cancer, oesophageal squamous-cell cancer, bladder cancer, cervical squamous-cell cancer, pancreatic cancer, glioblastomas, prostate cancer, osteosarcoma, colorectal cancer, head and neck cancer and malignant melanoma, gastric cancer, glioma, and nasopharyngeal cancer.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.13636
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15129593', '11687611', '11415785', '11415552', '11344938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8205299123053191
- 35 USC 102 Novelty (BERT): 0.6092543785942738
- Combined Prediction Score: 0.7994023589342146
- Mean Citation Score: 344.67509800000005
- Max Citation Score: 594.41205
- Similarity Product: 476.3260717413783

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test